Browsing by Author "Головатюк, Людмила"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    ИСПОЛЬЗОВАНИЕ НОВЫХ ТЕХНОЛОГИЙ В ОЦЕНКЕ ПИТАНИЯ БОЛЬНЫХ С ХРОНИЧЕСКИМИ ЗАБОЛЕВАНИЯМИ ПЕЧЕНИ
    (CEP USM, 2024) Головатюк, Людмила; Лупашко, Юлиана; Березовская, Елена
    There is a need for simple, accurate and non-invasive methods for assessing body composition, such as bioelectrical impedance analysis (BIA). 282 patients with chronic liver pathology were examined. 75 patients with chronic viral hepatitis (HVC group), 96 patients with hepatic steatosis (SH group), 111 patients with liver cirrhosis (LC group). BIA indicators: BMI, percentage of body fat (PBF), indicator of the proportion of visceral fat (PVF) and total cholesterol, HDL, LDL and triglycerides (TG) in serum were determined. BMI in the SH group - 30.29±0.50, in the HVC group - 28.13±0.65, in the LC group - 22.69±0.16 kg/m². PBF: 36.02±1.06 (SH group), 34.16±1.33 (HVC group), 22.90±0.85% (LC group). LDL: 3.73±0.13 (SH group), 3.02±0.14 (HVC group), 2.35±0.15 mmol/l (LC group). TG: 1.87±0.11 (SH group), 1.48±0.22 (HVC group), 0.80±0.04 mmol/l (LC group). The highest rates of both biochemical and BIA are observed in the SH group, and the lowest in the LC group. To study lipid metabolism of patients with chronic liver disease BIA can be recommended.
  • Thumbnail Image
    Item
    Физиологическое значение и методы диагностики жировой ткани у пациентов с хроническими гепатопатиями
    (Editura USM, 2024) Головатюк, Людмила; Лупашко, Юлианна; Березовская, Елена
    Excess body weight is a serious health problem. Adipose tissue is involved in metabolic disorders formation. White and brown adipose tissue are organs that have anatomical, functional and genetic diversity. The aim: to study the functions and physiological significance and diagnostic methods of adipose tissue in patients with chronic hepatopathies. There were examined 591 patients with chronic hepatopathies: 177 with BMI <25 (Group I), 228 with BMI 25-30 (Group II) and 186 patients with BMI >30 kg/m2 (Group III). In group I, BMI was 23.20 ± 0.19 kg/m², and waist circumference was 89.62 ± 0.73 cm; in group II, these indicators were: 27.62 ± 0.12 and 99.32 ± 0.61 respectively, and in group III: 34.21 ± 0.32 and 112.32 ± 0.82, respectively. The highest percentage of body fat and visceral fat indexes were observed in patients with BMI >30 kg/m2. Diagnosis of metabolic disorders in patients with chronic hepatopathies should include BMI and waist circumference evaluation, and, if necessary, supplemented by determining the percentage of fat and visceral fat data using bioimpedance analysis.